ASPIRE BIOPHARMA HOLDINGS, INC. Stock-Based Compensation
ASPIRE BIOPHARMA HOLDINGS, INC. (ASBP) reported Stock-Based Compensation of $157.50 thousand for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-13.
Financial Statements › Cash Flow › Operating Activities
us-gaap:ShareBasedCompensation · last filed 2026-08-13
- ASPIRE BIOPHARMA HOLDINGS, INC. share-based payment arrangement, noncash expense for the quarter ending 2026-06-30 was $144.09K.
- ASPIRE BIOPHARMA HOLDINGS, INC. share-based payment arrangement, noncash expense for the quarter ending 2026-03-31 was $13.41K, a 99.91% decline year-over-year.
- ASPIRE BIOPHARMA HOLDINGS, INC. share-based payment arrangement, noncash expense for the quarter ending 2025-12-31 was $0.00.
- ASPIRE BIOPHARMA HOLDINGS, INC. share-based payment arrangement, noncash expense for the quarter ending 2025-09-30 was $0.00.
| Period end | Share-based Payment Arrangement, Noncash Expense 3 month | Share-based Payment Arrangement, Noncash Expense 6 month | Share-based Payment Arrangement, Noncash Expense 9 month | Share-based Payment Arrangement, Noncash Expense 12 month |
|---|---|---|---|---|
| 2026-06-30 | $144.09K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-13 | $157.50K 10-Q · filed 2026-08-13 | $157.50K derived: sum of 3 quarters · filed 2026-08-13 | $157.50K derived: sum of 4 quarters · filed 2026-08-13 |
| 2026-03-31 | $13.41K 10-Q · filed 2026-05-15 | $13.41K derived: sum of 2 quarters · filed 2026-05-15 | $13.41K derived: sum of 3 quarters · filed 2026-05-15 | $13.41K derived: sum of 4 quarters · filed 2026-08-13 |
| 2025-12-31 | $0.00 derived: S-1/A 12 month − 10-Q 9 month · filed 2026-04-10 | $0.00 derived: sum of 2 quarters · filed 2026-04-10 | $0.00 derived: sum of 3 quarters · filed 2026-08-13 | $14.13M S-1/A · filed 2026-04-10 |
| 2025-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-14 | $0.00 derived: sum of 2 quarters · filed 2026-08-13 | $14.13M 10-Q · filed 2025-11-14 | |
| 2025-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-13 | $14.13M 10-Q · filed 2026-08-13 | ||
| 2025-03-31 | $14.13M 10-Q · filed 2026-05-15 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| BIOVIE INC. (BIVI) | United States | $0.012B | |
| Tempest Therapeutics, Inc. (TPST) | United States | $0.013B | |
| ADIAL PHARMACEUTICALS, INC. (ADIL) | United States | $0.012B | |
| Phio Pharmaceuticals Corp. (PHIO) | United States | $0.012B | -0.92 |
| AEON Biopharma, Inc. (AEON) | United States | $0.013B | -0.36 |
| Scienture Holdings, Inc. (SCNX) | United States | $0.012B | -0.38 |
| MUSTANG BIO, INC. (MBIO) | United States | $0.013B | |
| Vistagen Therapeutics, Inc. (VTGN) | United States | $0.013B | -0.14 |
| KIORA PHARMACEUTICALS INC (KPRX) | United States | $0.012B | |
| Dare Bioscience, Inc. (DARE) | United States | $0.011B |